Beyond alprazolam, lorazepam, and clonazepam, the BZD class includes specific agents that fill niche roles. Knowing each helps you match the right BZD to the situation.
- Class
- Benzodiazepines (specific agents)
- Mechanism
- GABA-A positive allosteric modulators
- Typical dose
- Drug-specific
- Half-life
- Diazepam ~30-100h via active metabolites; midazolam ~2h; oxazepam ~8h
- FDA indications
- Diazepam: anxiety, alcohol withdrawal, muscle spasm. Midazolam: procedural sedation, status epilepticus, anesthesia. Oxazepam/temazepam: anxiety/sleep in elderly/hepatic impairment. Chlordiazepoxide: alcohol withdrawal.
- Key adverse effects
- Class effects: sedation, cognitive impairment, falls, dependence
- Representative agents
- Diazepam (long acting, active metabolites), midazolam (very short, IV/IM/IN), oxazepam (no active metabolites, useful elderly), temazepam (intermediate, sleep), chlordiazepoxide (alcohol withdrawal)
Black box: Concomitant opioid use; abuse potential and dependence
Each has specific niche. Diazepam: long half-life buffers withdrawal but accumulates in elderly. Midazolam: very rapid onset/offset for procedural use. Oxazepam/temazepam: glucuronidated only, preferred in hepatic impairment. Chlordiazepoxide (Librium): historical alcohol withdrawal workhorse.
Diazepam — Valium. Long half-life (often >100 hours when active metabolites are counted), making it useful for alcohol withdrawal protocols where slow tapering matters. Also used for muscle spasm and as adjunct in seizure protocols. The accumulation in elderly is the major concern — diazepam can produce prolonged sedation and falls in older patients. Lorazepam is generally safer in geriatric populations.
Midazolam — Versed. Very short half-life (~2 hours), rapid onset. The procedural sedation BZD — used in radiology, endoscopy, dental procedures. Available IV, IM, intranasal, oral. The rapid offset is what makes it useful for procedures where prolonged sedation isn't wanted. Anterograde amnesia is part of the profile (often desired in procedural use).
Oxazepam and temazepam — both glucuronidation-only metabolism, like lorazepam. Useful in hepatic impairment and elderly. Temazepam is the most common BZD prescribed for insomnia specifically.
Chlordiazepoxide — Librium. Historical workhorse for alcohol withdrawal. Long half-life with active metabolites. Largely supplanted by lorazepam for inpatient alcohol withdrawal, but still in use in some protocols.
The LOT principle — Lorazepam, Oxazepam, Temazepam — captures the three glucuronidation-only BZDs. In hepatic impairment, in elderly, in patients with complex polypharmacy, these are the safer choices because they don't undergo oxidative metabolism that would be affected.
- Cost
- All generic, ~$10-30/month for outpatient agents. Midazolam IV/IM/IN procedural.
- Generic status
- All generic.
- Formulary typical
- Tier 1 generics.
- Access friction
- Schedule IV. Midazolam in acute settings widely available; outpatient midazolam (Nayzilam intranasal for seizure rescue) requires specific indication.
Prescriber tip: For elderly or hepatic impairment, LOT (lorazepam, oxazepam, temazepam) preferred. Temazepam specifically for sleep; outpatient diazepam declining.
Knowing which BZD fits which clinical situation is what makes the class usable safely. The choice is rarely arbitrary.
Diazepam, midazolam, and the remaining benzodiazepines span the pharmacokinetic extremes — from diazepam's very long active metabolites to midazolam's ultrashort action.
Mechanism note: The benzodiazepine class is best navigated by kinetics — match half-life and metabolism to the task: long/self-tapering for withdrawal, ultrashort for procedures, glucuronidated for hepatic impairment.